ArticlePathologie (Heidelberg, Germany)2026
[Lymphomas of the thymus and mediastinum].
Article in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphocyterich lesions account for the majority of relevant differential diagnoses in the anterior mediastinum and include non-neoplastic and neoplastic entities. With only 10-15% of cases, lymphomas account for a relatively small proportion of these. A systematic approach and consideration of epidemiological and clinical background information are crucial for a correct diagnosis, particularly in the case of small biopsies. A few entities dominate among mediastinal lymphomas: nodular sclerosing Hodgkin lymphoma (NSCHL) is the most common form, accounting for 50-70% of cases, followed by primary mediastinal large B‑cell lymphoma (PMBL) and T‑lymphoblastic lymphoma (T-LBL). Epidemiologically, all of these tumors occur predominantly in children and young adults; all other lymphomas are rare and mostly affect older patients. In this context, typical practical diagnostic challenges include the distinction of B‑cell lymphomas from other B‑cell-dominated lesions, the distinction of T‑LBL from thymomas, the subtyping of sclerotic lymphomas (NSCHL, PMBL, gray zone lymphomas) and their separation from other sclerosing processes. This overview focuses on the discussion of these practice-relevant diagnostic problems.
Indexed as
Identifiers
41537898What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.